Edaravone tablet (Shanghai Auzone Biological Technology)

依达拉奉片 (上海澳宗生物）

Report date: 2026/05/25 20:02:40

Base Information

Drug NameEdaravone tablet (Shanghai Auzone Biological Technology)
Drug Alias Name依达拉奉片 (2.2类改良型)Edaravone tablet (Hangzhou Zhongmei Huadong Pharma)依达拉奉片 (杭州中美华东制药）AUKONTALSTTYP-01
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFree radicals scavengersAnti-oxidative stress
TargetsFree radicals
Therapy Area/IndicationsIschemic StrokeAutism Spectrum DisorderAmyotrophic Lateral Sclerosis +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaMainland China
CombinationsNo
Global Highest StatusNDA/BLA
Highest Status in ChinaNDA/BLA
Originator CompaniesShanghai Auzone Biological Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHuadong Medicine Co LtdSuzhou Aozong Biotechnology Co., Ltd.Shanghai Auzone Biological Technology Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsIschemic StrokeAutism Spectrum DisorderAmyotrophic Lateral Sclerosis +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A